Academic Textbook: Diagnosis and Management of Complications of COVID-19
Keywords:
COVID-19, COVID-19 Complications, Disease Diagnosis, Clinical ManagementAbstract
Long-term complications are frequent in recovering COVID-19 cases. However, long-term complications of COVID-19 are currently unclear. If similar rate of long-term complications emerge following COVID-19, then we can expect a crashing wave of complications, which will have huge implication for treatment of the stretched healthcare resources in every country. A diverse group of symptoms, increasingly referred to as “Long COVID,” is also being reported in cases who did not need hospital treatment. These cases report a wide variety of manifestations, persisting for many months after acute infection. To date, most investigations on long COVID have been led by cases, and it proposes this is a frequent and disabling disease. More investigation informing clinical recommendations and our understanding of the mechanisms underlying this disease is urgently needed.
References
1. Boraschi P, Giugliano L, Mercogliano G, Donati F, Romano S, Neri E. Abdominal and gastrointestinal manifestations in COVID-19 patients: Is imaging useful? World J Gastroenterol. 2021;27(26):4143-59.
2. Berdowska I, Matusiewicz M. Cathepsin L, transmembrane peptidase/serine subfamily member 2/4, and other host proteases in COVID-19 pathogenesis - with impact on gastrointestinal tract. World J Gastroenterol. 2021;27(39):6590-600.
3. Aslan AT, Şimşek H. Clinical Features and Pathophysiological Mechanisms of COVID-19-associated Gastrointestinal Manifestations. Euroasian J Hepatogastroenterol. 2021;11(2):81-6.
4. Kostoff RN, Briggs MB, Kanduc D, Shores DR, Kovatsi L, Drakoulis N, et al. Contributing factors common to COVID‑19 and gastrointestinal cancer. Oncol Rep. 2022;47(1).
5. M DER, Pasculli A, Rondelli F, Mariani L, Avenia S, Ceccarelli G, et al. Could diagnostic and therapeutic delay affect the prognosis of gastrointestinal primary malignancies in the COVID-19 pandemic era? Minerva Surg. 2021;76(5):467-76.
6. Bulte JP, Postma N, Beukema M, Inberg B, Stegeman AG, van der Hoeven H. COVID 19 and the risk of gastro-intestinal perforation: A case series and literature review. J Crit Care. 2022;67:100-3.
7. Rao A, Puertolas M, Runde J. COVID-19 and Gastrointestinal and Hepatobiliary Diseases. Pediatr Ann. 2021;50(8):e315-e9.
8. Pola A, Murthy KS, Santhekadur PK. COVID-19 and gastrointestinal system: A brief review. Biomed J. 2021;44(3):245-51.
9. Troisi J, Venutolo G, Pujolassos Tanyà M, Delli Carri M, Landolfi A, Fasano A. COVID-19 and the gastrointestinal tract: Source of infection or merely a target of the inflammatory process following SARS-CoV-2 infection? World J Gastroenterol. 2021;27(14):1406-18.
10. Nozari N. COVID-19 Outbreak and its Burden on a New Wave of Functional Gastrointestinal Disorders. Middle East J Dig Dis. 2021;13(2):91-4.
11. Bhurwal A, Minacapelli CD, Orosz E, Gupta K, Tait C, Dalal I, et al. COVID-19 status quo: Emphasis on gastrointestinal and liver manifestations. World J Gastroenterol. 2021;27(46):7969-81.
12. Ozkurt Z, Çınar Tanrıverdi E. COVID-19: Gastrointestinal manifestations, liver injury and recommendations. World J Clin Cases. 2022;10(4):1140-63.
13. Mohamed DZ, Ghoneim ME, Abu-Risha SE, Abdelsalam RA, Farag MA. Gastrointestinal and hepatic diseases during the COVID-19 pandemic: Manifestations, mechanism and management. World J Gastroenterol. 2021;27(28):4504-35.
14. Law MF, Ho R, Law KWT, Cheung CKM. Gastrointestinal and hepatic side effects of potential treatment for COVID-19 and vaccination in patients with chronic liver diseases. World J Hepatol. 2021;13(12):1850-74.
15. Shafiee S, Cegolon L, Khafaei M, Gholami N, Zhao S, Khalesi N, et al. Gastrointestinal cancers, ACE-2/TMPRSS2 expression and susceptibility to COVID-19. Cancer Cell Int. 2021;21(1):431.
16. Ribeiro-Junior MAF, Augusto SS, Elias YGB, Costa CTK, Néder PR. GASTROINTESTINAL COMPLICATIONS OF CORONAVIRUS DISEASE (COVID-19). Arq Bras Cir Dig. 2022;34(3):e1620.
17. Chen F, Dai Z, Huang C, Chen H, Wang X, Li X. Gastrointestinal Disease and COVID-19: A Review of Current Evidence. Dig Dis. 2021:1-9.
18. Calitri C, Fumi I, Ignaccolo MG, Banino E, Benetti S, Lupica MM, et al. Gastrointestinal involvement in paediatric COVID-19 - from pathogenesis to clinical management: A comprehensive review. World J Gastroenterol. 2021;27(23):3303-16.
19. Zhang MM, Chen LN, Qian JM. Gastrointestinal manifestations and possible mechanisms of COVID-19 in different periods. J Dig Dis. 2021;22(12):683-94.
20. Kariyawasam JC, Jayarajah U, Riza R, Abeysuriya V, Seneviratne SL. Gastrointestinal manifestations in COVID-19. Trans R Soc Trop Med Hyg. 2021;115(12):1362-88.
21. Groff A, Kavanaugh M, Ramgobin D, McClafferty B, Aggarwal CS, Golamari R, et al. Gastrointestinal Manifestations of COVID-19: A Review of What We Know. Ochsner J. 2021;21(2):177-80.
22. Yang Y, Huang W, Fan Y, Chen GQ. Gastrointestinal Microenvironment and the Gut-Lung Axis in the Immune Responses of Severe COVID-19. Front Mol Biosci. 2021;8:647508.
23. Velikova T, Snegarova V, Kukov A, Batselova H, Mihova A, Nakov R. Gastrointestinal mucosal immunity and COVID-19. World J Gastroenterol. 2021;27(30):5047-59.
24. Pegoraro F, Trapani S, Indolfi G. Gastrointestinal, hepatic and pancreatic manifestations of COVID-19 in children. Clin Res Hepatol Gastroenterol. 2021;46(4):101818.
25. Azimirad M, Noori M, Raeisi H, Yadegar A, Shahrokh S, Asadzadeh Aghdaei H, et al. How Does COVID-19 Pandemic Impact on Incidence of Clostridioides difficile Infection and Exacerbation of Its Gastrointestinal Symptoms? Front Med (Lausanne). 2021;8:775063.
26. Ghazanfar H, Kandhi S, Shin D, Muthumanickam A, Gurjar H, Qureshi ZA, et al. Impact of COVID-19 on the Gastrointestinal Tract: A Clinical Review. Cureus. 2022;14(3):e23333.
27. Gupta R, Gupta J, Ammar H. Impact of COVID-19 on the outcomes of gastrointestinal surgery. Clin J Gastroenterol. 2021;14(4):932-46.
28. Rahban M, Stanek A, Hooshmand A, Khamineh Y, Ahi S, Kazim SN, et al. Infection of Human Cells by SARS-CoV-2 and Molecular Overview of Gastrointestinal, Neurological, and Hepatic Problems in COVID-19 Patients. J Clin Med. 2021;10(21).
29. Delgado-Gonzalez P, Gonzalez-Villarreal CA, Roacho-Perez JA, Quiroz-Reyes AG, Islas JF, Delgado-Gallegos JL, et al. Inflammatory effect on the gastrointestinal system associated with COVID-19. World J Gastroenterol. 2021;27(26):4160-71.
30. National Institute for Health and Care Excellence: Guidelines. COVID-19 rapid guideline: gastrointestinal and liver conditions treated with drugs affecting the immune response. London: National Institute for Health and Care Excellence (NICE)
Copyright © NICE 2021.; 2021.
31. Devaux CA, Lagier JC, Raoult D. New Insights Into the Physiopathology of COVID-19: SARS-CoV-2-Associated Gastrointestinal Illness. Front Med (Lausanne). 2021;8:640073.
32. Rehana RW, Fahad H, Sadiq O, Schairer J. Outcomes of Gastrointestinal Bleeding During the COVID-19 Pandemic. Gastro Hep Adv. 2022;1(3):342-3.
33. Zhang H, Shao B, Dang Q, Chen Z, Zhou Q, Luo H, et al. Pathogenesis and Mechanism of Gastrointestinal Infection With COVID-19. Front Immunol. 2021;12:674074.
34. Jin B, Singh R, Ha SE, Zogg H, Park PJ, Ro S. Pathophysiological mechanisms underlying gastrointestinal symptoms in patients with COVID-19. World J Gastroenterol. 2021;27(19):2341-52.
35. Fang LG, Zhou Q. Remarkable gastrointestinal and liver manifestations of COVID-19: A clinical and radiologic overview. World J Clin Cases. 2021;9(19):4969-79.
36. Tan X, Guo J, Chen Z, Königsrainer A, Wichmann D. Systematic review and meta-analysis of clinical outcomes of COVID-19 patients undergoing gastrointestinal endoscopy. Therap Adv Gastroenterol. 2021;14:17562848211042185.
37. Scarpellini E, Balsiger LM, Maurizi V, Rinninella E, Gasbarrini A, Giostra N, et al. Zinc and gut microbiota in health and gastrointestinal disease under the COVID-19 suggestion. Biofactors. 2022;48(2):294-306.
38. Azinheira Nobrega Cruz N, Gonçalves de Oliveira LC, Tedesco Silva Junior H, Osmar Medina Pestana J, Casarini DE. Angiotensin-Converting Enzyme 2 in the Pathogenesis of Renal Abnormalities Observed in COVID-19 Patients. Front Physiol. 2021;12:700220.
39. Hanna RM, Ferrey A, Rhee CM, Sam R, Pearce D, Kalantar-Zadeh K, et al. Building a hemodiafiltration system from readily available components for continuous renal replacement therapy under disasters and pandemics: preparing for an acute kidney injury surge during COVID-19. Curr Opin Nephrol Hypertens. 2021;30(1):93-6.
40. Singh Y, Ali H, Alharbi KS, Almalki WH, Kazmi I, Al-Abbasi FA, et al. Calcium sensing receptor hyperactivation through viral envelop protein E of SARS CoV2: A novel target for cardio-renal damage in COVID-19 infection. Drug Dev Res. 2021;82(6):784-8.
41. Guven G, Ince C, Topeli A, Caliskan K. Cardio-Pulmonary-Renal Consequences of Severe COVID-19. Cardiorenal Med. 2021;11(3):133-9.
42. Touyz RM, Boyd MOE, Guzik T, Padmanabhan S, McCallum L, Delles C, et al. Cardiovascular and Renal Risk Factors and Complications Associated With COVID-19. CJC Open. 2021;3(10):1257-72.
43. Switzer B, Haanen J, Lorigan PC, Puzanov I, Turajlic S. Clinical and immunologic implications of COVID-19 in patients with melanoma and renal cell carcinoma receiving immune checkpoint inhibitors. J Immunother Cancer. 2021;9(7).
44. Ramanathan M, Chueng T, Fernandez E, Gonzales-Zamora J. Concomitant renal and splenic infarction as a complication of COVID-19: a case report and literature review. Infez Med. 2020;28(4):611-5.
45. Stevens JS, Velez JCQ, Mohan S. Continuous renal replacement therapy and the COVID pandemic. Semin Dial. 2021;34(6):561-6.
46. Bitencourt L, Pedrosa AL, de Brito S, Fróes ACF, de Carvalho ST, Fonseca GG, et al. COVID-19 and Renal Diseases: An Update. Curr Drug Targets. 2021;22(1):52-67.
47. Perico N, Perico L, Ronco C, Remuzzi G. COVID-19 and the Kidney: Should Nephrologists Care about COVID-19 rather than Maintaining Their Focus on Renal Patients? Contrib Nephrol. 2021;199:229-43.
48. Chen X, Yu C, Jing H, Wang C, Zhao X, Zhang J, et al. COVID-19 associated thromboinflammation of renal capillary: potential mechanisms and treatment. Am J Transl Res. 2020;12(12):7640-56.
49. Kaye AD, Okeagu CN, Tortorich G, Pham AD, Ly EI, Brondeel KC, et al. COVID-19 impact on the renal system: Pathophysiology and clinical outcomes. Best Pract Res Clin Anaesthesiol. 2021;35(3):449-59.
50. Elhadedy MA, Marie Y, Halawa A. COVID-19 in Renal Transplant Recipients: Case Series and a Brief Review of Current Evidence. Nephron. 2021;145(2):192-8.
51. Moreno NF, McAdams R, Goss JA, Galvan NTN. COVID-19 Vaccine Efficacy and Immunogenicity in End-Stage Renal Disease Patients and Kidney Transplant Recipients. Curr Transplant Rep. 2022:1-11.
52. Lau WL, Zuckerman JE, Gupta A, Kalantar-Zadeh K. The COVID-Kidney Controversy: Can SARS-CoV-2 Cause Direct Renal Infection? Nephron. 2021;145(3):275-9.
53. Roberto P, Francesco L, Emanuela C, Giorgia G, Pasquale N, Sara D. Current treatment of COVID-19 in renal patients: hope or hype? Intern Emerg Med. 2020;15(8):1389-98.
54. Ahmadian E, Zununi Vahed S, Mammadova S, Abediazar S. Immunosuppressant Management in Renal Transplant Patients with COVID-19. Biomed Res Int. 2021;2021:9318725.
55. Mohamadi Yarijani Z, Najafi H. Kidney injury in COVID-19 patients, drug development and their renal complications: Review study. Biomed Pharmacother. 2021;142:111966.
56. Toapanta N, Torres IB, Sellarés J, Chamoun B, Serón D, Moreso F. Kidney transplantation and COVID-19 renal and patient prognosis. Clin Kidney J. 2021;14(Suppl 1):i21-i9.
57. Brunori G, Reboldi G, Aucella F. Lessons Learnt during the COVID-19 Pandemic: For Patients with End-Stage Renal Disease, We Should Prioritize Home-Based Treatment and Telemedicine. Kidney Blood Press Res. 2021;46(1):11-6.
58. Akbulut G, Gencer-Bingol F. Medical nutritional therapy for renal transplantation in the COVID-19 pandemic. World J Transplant. 2021;11(6):212-9.
59. Panteli AE, Theofilis P, Vordoni A, Vlachopanos G, Koukoulaki M, Kalaitzidis RG. A Narrative Review of Recent Studies on the Role of Vitamin D in the Prevention of Cardiac and Renal Risk and Additional Considerations for COVID-19 Vulnerability. Curr Vasc Pharmacol. 2022;20(2):168-77.
60. National Institute for Health and Care Excellence: Guidelines. COVID 19 rapid guideline: renal transplantation. London: National Institute for Health and Care Excellence (NICE)
Copyright © NICE 2020.; 2020.
61. Guillouët S, Thibault C. [Reception of patients with chronic renal failure, COVID-19]. Rev Infirm. 2021;70(271):41-2.
62. Marra F, Smolders EJ, El-Sherif O, Boyle A, Davidson K, Sommerville AJ, et al. Recommendations for Dosing of Repurposed COVID-19 Medications in Patients with Renal and Hepatic Impairment. Drugs R D. 2021;21(1):9-27.
63. Dugbartey GJ, Alornyo KK, Ohene BO, Boima V, Antwi S, Sener A. Renal consequences of the novel coronavirus disease 2019 (COVID-19) and hydrogen sulfide as a potential therapy. Nitric Oxide. 2022;120:16-25.
64. Plouffe B, Van Hooren T, Barton M, Nashid N, Demirkaya E, Norozi K, et al. Renal Infarcts-A Perplexing Case in the Middle of the COVID-19 Pandemic. Front Pediatr. 2021;9:669453.
65. Migliaccio MG, Di Mauro M, Ricciolino R, Spiniello G, Carfora V, Verde N, et al. Renal Involvement in COVID-19: A Review of the Literature. Infect Drug Resist. 2021;14:895-903.
66. Sagnelli C, Sica A, Gallo M, Peluso G, Varlese F, D'Alessandro V, et al. Renal involvement in COVID-19: focus on kidney transplant sector. Infection. 2021;49(6):1265-75.
67. Campos YM, Drumond ALV, de Matos Gamonal M, Parreira MP, Simões ESAC. Renal Involvement in Pediatric Patients with COVID-19: An Up-to-date Review. Curr Pediatr Rev. 2021;17(4):253-63.
68. Armaly Z, Kinaneh S, Skorecki K. Renal Manifestations of Covid-19: Physiology and Pathophysiology. J Clin Med. 2021;10(6).
69. Haq K, Mahmood F, Ghaly M. Renal manifestations, incidence, pathogenesis and implications on prognosis and mortality in COVID-19 patients: A review of current evidence and the potential for future directions. Clin Nephrol. 2021;96(2):67-81.
70. Shemies RS, Nagy E, Younis D, Sheashaa H. Renal replacement therapy for critically ill patients with COVID-19-associated acute kidney injury: A review of current knowledge. Ther Apher Dial. 2022;26(1):15-23.
71. Kute V, Varugese S, Prasad N, Shroff S, Agarwal SK. Renal Transplant Guidelines with Reference to COVID-19 Infection. Indian J Nephrol. 2020;30(3):176-8.
72. Khan S, Siddique R, Hao X, Lin Y, Liu Y, Wang X, et al. The COVID-19 infection in children and its association with the immune system, prenatal stress, and neurological complications. Int J Biol Sci. 2022;18(2):707-16.
73. Sriwastava S, Sharma K, Khalid SH, Bhansali S, Shrestha AK, Elkhooly M, et al. COVID-19 Vaccination and Neurological Manifestations: A Review of Case Reports and Case Series. Brain Sci. 2022;12(3).
74. Singh V, Allawadhi P, Khurana A, Banothu AK, Bharani KK. Critical neurological features of COVID-19: Role of imaging methods and biosensors for effective diagnosis. Sens Int. 2021;2:100098.
75. Mohamed MS, Johansson A, Jonsson J, Schiöth HB. Dissecting the Molecular Mechanisms Surrounding Post-COVID-19 Syndrome and Neurological Features. International journal of molecular sciences. 2022;23(8).
76. Moore P, Esmail F, Qin S, Nand S, Berg S. Hypercoagulability of COVID-19 and Neurological Complications: A Review. J Stroke Cerebrovasc Dis. 2022;31(1):106163.
77. Payus AO, Jeffree MS, Ohn MH, Tan HJ, Ibrahim A, Chia YK, et al. Immune-mediated neurological syndrome in SARS-CoV-2 infection: a review of literature on autoimmune encephalitis in COVID-19. Neurol Sci. 2022;43(3):1533-47.
78. Premraj L, Kannapadi NV, Briggs J, Seal SM, Battaglini D, Fanning J, et al. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis. J Neurol Sci. 2022;434:120162.
79. Shamsoddini A, Bazigar B, Dalvand H. Need to Perform Rehabilitation Exercises at Home by Parents of Children with Neurological Diseases to Maintain Performance During COVID-19 Lockdown. Iran J Child Neurol. 2021;15(4):9-14.
80. Mahboubi Mehrabani M, Karvandi MS, Maafi P, Doroudian M. Neurological complications associated with Covid-19; molecular mechanisms and therapeutic approaches. Rev Med Virol. 2022:e2334.
81. Siddique R, Khan S, Shabana, Li M, Xue M, Ghanim KA, et al. Neurological complications of COVID-19 in children and the associated immunological responses. J King Saud Univ Sci. 2022;34(3):101884.
82. Sarubbo F, El Haji K, Vidal-Balle A, Bargay Lleonart J. Neurological consequences of COVID-19 and brain related pathogenic mechanisms: A new challenge for neuroscience. Brain Behav Immun Health. 2022;19:100399.
83. Stafstrom CE. Neurological effects of COVID-19 in infants and children. Dev Med Child Neurol. 2022.
84. Singh KP, Agarwal R. Neurological Manifestations in COVID-19 Population: A Short Review. Ann Neurosci. 2021;28(1-2):94-100.
85. Mahdizade Ari M, Mohamadi MH, Shadab Mehr N, Abbasimoghaddam S, Shekartabar A, Heidary M, et al. Neurological manifestations in patients with COVID-19: A systematic review and meta-analysis. J Clin Lab Anal. 2022;36(5):e24403.
86. Ahmed AIE, Isam Farah Hassan R, Abbasher Hussien Mohamed Ahmed K, Taha Salah E, Eltahier Abdalla Omer M, M SH. Neurological manifestations of COVID-19: A potential gate to the determinants of a poor prognosis. Brain Behav. 2022:e2587.
87. Stefanou MI, Palaiodimou L, Bakola E, Smyrnis N, Papadopoulou M, Paraskevas GP, et al. Neurological manifestations of long-COVID syndrome: a narrative review. Ther Adv Chronic Dis. 2022;13:20406223221076890.
88. Vinciguerra C, Federico A. Neurological music therapy during the COVID-19 outbreak: updates and future challenges. Neurol Sci. 2022;43(6):3473-8.
89. Bhola S, Trisal J, Thakur V, Kaur P, Kulshrestha S, Bhatia SK, et al. Neurological toll of COVID-19. Neurol Sci. 2022;43(4):2171-86.
90. Kodidela S, Godse S, Kumar A, Nguyen XH, Cernasev A, Zhou L, et al. Nutraceuticals in HIV and COVID-19-Related Neurological Complications: Opportunity to Use Extracellular Vesicles as Drug Delivery Modality. Biology (Basel). 2022;11(2).
91. Singh D, Singh E. An overview of the neurological aspects in COVID-19 infection. J Chem Neuroanat. 2022;122:102101.
92. Ahmed JO, Ahmad SA, Hassan MN, Kakamad FH, Salih RQ, Abdulla BA, et al. Post COVID-19 neurological complications; a meta-analysis. Ann Med Surg (Lond). 2022;76:103440.
93. Arjmand B, Roudsari PP, Alavi-Moghadam S, Rezaei-Tavirani M, Tayanloo-Beik A, Mehrdad N, et al. Potential for Stem Cell-Based Therapy in the Road of Treatment for Neurological Disorders Secondary to COVID-19. Regen Eng Transl Med. 2021:1-15.
94. Özkan Oktay E, Tuncay S, Kaman T, Karasakal Ö F, Özcan Ö, Soylamiş T, et al. An update comprehensive review on the status of COVID-19: vaccines, drugs, variants and neurological symptoms. Turk J Biol. 2021;45(4):342-57.
95. de Souza A, Jacques R, Mohan S. Vaccine-induced functional neurological disorders in the Covid-19 era. Can J Neurol Sci. 2022:1-15.
96. Gourret Baumgart J, Kane H, El-Hage W, Deloyer J, Maes C, Lebas MC, et al. The Early Impacts of the COVID-19 Pandemic on Mental Health Facilities and Psychiatric Professionals. Int J Environ Res Public Health. 2021;18(15).
97. Yoshikawa Y, Kumazaki H, Kato TA. Future perspectives of robot psychiatry: can communication robots assist psychiatric evaluation in the COVID-19 pandemic era? Curr Opin Psychiatry. 2021;34(3):277-86.
98. Diaz A, Baweja R, Bonatakis JK, Baweja R. Global health disparities in vulnerable populations of psychiatric patients during the COVID-19 pandemic. World J Psychiatry. 2021;11(4):94-108.
99. Stefano GB. Historical Insight into Infections and Disorders Associated with Neurological and Psychiatric Sequelae Similar to Long COVID. Med Sci Monit. 2021;27:e931447.
100. Miller LH, Parks J, Yowell R. The Impact of COVID-19 on Financing of Psychiatric Services. Psychiatr Clin North Am. 2022;45(1):161-77.
101. Puangsri P, Jinanarong V, Wattanapisit A. Impacts on and Care of Psychiatric Patients during the Outbreak of COVID-19. Clin Pract Epidemiol Ment Health. 2021;17:52-60.
102. Albert H, Heipel D, Thakre TP, Hess O, Cooper K, Pryor R, et al. Management of the COVID-19-Infected Psychiatric Inpatients: Unique Infection Prevention Considerations and Evolving Strategies. Curr Treat Options Infect Dis. 2021;13(4):165-74.
103. Llach CD, Vieta E. Mind long COVID: Psychiatric sequelae of SARS-CoV-2 infection. Eur Neuropsychopharmacol. 2021;49:119-21.
104. Ghasemiyeh P, Mortazavi N, Karimzadeh I, Vazin A, Mahmoudi L, Moghimi-Sarani E, et al. Psychiatric Adverse Drug Reactions and Potential Anti-COVID-19 Drug Interactions with Psychotropic Medications. Iran J Pharm Res. 2021;20(3):66-77.
105. Balasubramanian I, Faheem A, Padhy SK, Menon V. Psychiatric adverse reactions to COVID-19 vaccines: A rapid review of published case reports. Asian J Psychiatr. 2022;71:103129.
106. Schou TM, Joca S, Wegener G, Bay-Richter C. Psychiatric and neuropsychiatric sequelae of COVID-19 - A systematic review. Brain Behav Immun. 2021;97:328-48.
107. Troglio da Silva FC, Neto MLR. Psychiatric disorders in health professionals during the COVID-19 pandemic: A systematic review with meta-analysis. J Psychiatr Res. 2021;140:474-87.
108. Kalyanasundaram S, Hemchand L, Sivakumar T. Psychiatric Rehabilitation During COVID-19 Pandemic: Richmond Fellowship Society (I), Bangalore Branch Experience. J Psychosoc Rehabil Ment Health. 2022;9(1):117-22.
109. Putri C, Arisa J, Hananto JE, Hariyanto TI, Kurniawan A. Psychiatric sequelae in COVID-19 survivors: A narrative review. World J Psychiatry. 2021;11(10):821-9.
110. Deolmi M, Pisani F. Psychological and psychiatric impact of COVID-19 pandemic among children and adolescents. Acta Biomed. 2020;91(4):e2020149.
111. Wan Mohd Yunus WMA, Kauhanen L, Sourander A, Brown JSL, Peltonen K, Mishina K, et al. Registered psychiatric service use, self-harm and suicides of children and young people aged 0-24 before and during the COVID-19 pandemic: a systematic review. Child Adolesc Psychiatry Ment Health. 2022;16(1):15.
112. Pilecki M, Dimter A, Siwek M, Styczeń K, Rodak W, Krupa A, et al. Transformation and operation of a uniform psychiatric ward dedicated to COVID-19 patients during the pandemic. Psychiatr Pol. 2020;54(5):865-75.
113. Xie Q, Liu XB, Xu YM, Zhong BL. Understanding the psychiatric symptoms of COVID-19: a meta-analysis of studies assessing psychiatric symptoms in Chinese patients with and survivors of COVID-19 and SARS by using the Symptom Checklist-90-Revised. Transl Psychiatry. 2021;11(1):290.
114. Peiris S, Ordunez P, DiPette D, Padwal R, Ambrosi P, Toledo J, et al. Cardiac Manifestations in Patients with COVID-19: A Scoping Review. Glob Heart. 2022;17(1):2.
115. Singh J, Durr MR, Deptuch E, Sultana S, Mehta N, Garcia S, et al. Cardiac Registries During the COVID-19 Pandemic: Lessons Learned. Curr Cardiol Rep. 2022:1-7.
116. Gupta AK, Leslie A, Hewitt JN, Kovoor JG, Ovenden CD, Edwards S, et al. Cardiac surgery on patients with COVID-19: a systematic review and meta-analysis. ANZ J Surg. 2022;92(5):1007-14.
117. Brady WJ, Chavez S, Gottlieb M, Liang SY, Carius B, Koyfman A, et al. Clinical update on COVID-19 for the emergency clinician: Cardiac arrest in the out-of-hospital and in-hospital settings. Am J Emerg Med. 2022;57:114-23.
118. Freund O, Eviatar T, Bornstein G. Concurrent myopathy and inflammatory cardiac disease in COVID-19 patients: a case series and literature review. Rheumatol Int. 2022;42(5):905-12.
119. Saha SA, Russo AM, Chung MK, Deering TF, Lakkireddy D, Gopinathannair R. COVID-19 and Cardiac Arrhythmias: a Contemporary Review. Curr Treat Options Cardiovasc Med. 2022:1-21.
120. Maitz T, Parfianowicz D, Vojtek A, Rajeswaran Y, Vyas AV, Gupta R. COVID-19 Cardiovascular Connection: A Review of Cardiac Manifestations in COVID-19 Infection and Treatment Modalities. Curr Probl Cardiol. 2022:101186.
121. Almamlouk R, Kashour T, Obeidat S, Bois MC, Maleszewski JJ, Omrani OA, et al. COVID-19-Associated cardiac pathology at the postmortem evaluation: a collaborative systematic review. Clin Microbiol Infect. 2022.
122. Katwa LC, Mendoza C, Clements M. CVD and COVID-19: Emerging Roles of Cardiac Fibroblasts and Myofibroblasts. Cells. 2022;11(8).
123. Hwang R, Fan T, Bowe R, Louis M, Bertram M, Morris NR, et al. Home-based and remote functional exercise testing in cardiac conditions, during the covid-19 pandemic and beyond: a systematic review. Physiotherapy. 2021;115:27-35.
124. Magnocavallo M, Vetta G, Bernardini A, Piro A, Mei MC, Di Iorio M, et al. Impact of COVID-19 Pandemic on Cardiac Electronic Device Management and Role of Remote Monitoring. Card Electrophysiol Clin. 2022;14(1):125-31.
125. de Lange M, Carvalho AS, Brito Fernandes Ó, Lingsma H, Klazinga N, Kringos D. The Impact of the COVID-19 Pandemic on Hospital Services for Patients with Cardiac Diseases: A Scoping Review. Int J Environ Res Public Health. 2022;19(6).
126. Jafari-Oori M, Moradian ST, Ebadi A, Jafari M, Dehi M. Incidence of cardiac complications following COVID-19 infection: An umbrella meta-analysis study. Heart Lung. 2022;52:136-45.
127. Holland DJ, Blazak PL, Martin J, Broom J, Poulter RS, Stanton T. Myocarditis and Cardiac Complications Associated With COVID-19 and mRNA Vaccination: A Pragmatic Narrative Review to Guide Clinical Practice. Heart Lung Circ. 2022.
128. Siripanthong B, Asatryan B, Hanff TC, Chatha SR, Khanji MY, Ricci F, et al. The Pathogenesis and Long-Term Consequences of COVID-19 Cardiac Injury. JACC Basic Transl Sci. 2022;7(3):294-308.
129. Cecchetto A, Nistri S, Baroni G, Torreggiani G, Aruta P, Pergola V, et al. Role of Cardiac Imaging Modalities in the Evaluation of COVID-19-Related Cardiomyopathy. Diagnostics (Basel). 2022;12(4).
130. Batta Y, King C, Johnson J, Haddad N, Boueri M, Haddad G. Sequelae and Comorbidities of COVID-19 Manifestations on the Cardiac and the Vascular Systems. Front Physiol. 2021;12:748972.
131. Rasmi Y, Mosa OF, Alipour S, Heidari N, Javanmard F, Golchin A, et al. Significance of Cardiac Troponins as an Identification Tool in COVID-19 Patients Using Biosensors: An Update. Front Mol Biosci. 2022;9:821155.
132. Pilarczyk K, Nina V, Boshkov L, Ferdman B, Farkas EA, Burnham N, et al. Surviving the Struggle of COVID-19: Practical Recommendations for Pediatric/Adult Cardiology and Cardiac Surgical Programs in Resource-Limited Settings: a Review. Braz J Cardiovasc Surg. 2022;37(1):99-109.
133. Niebel D, Novak N, Wilhelmi J, Ziob J, Wilsmann-Theis D, Bieber T, et al. Cutaneous Adverse Reactions to COVID-19 Vaccines: Insights from an Immuno-Dermatological Perspective. Vaccines (Basel). 2021;9(9).
134. Sharma S, Raby E, Prasad Kumarasinghe S. Cutaneous manifestations and dermatological sequelae of Covid-19 infection compared to those from other viruses. Australas J Dermatol. 2021;62(2):141-50.
135. Mohseni Afshar Z, Babazadeh A, Hasanpour A, Barary M, Sayad B, Janbakhsh A, et al. Dermatological manifestations associated with COVID-19: A comprehensive review of the current knowledge. J Med Virol. 2021;93(10):5756-67.
136. Panda M, Agarwal A, Hassanandani T. Dermatological Manifestations of COVID-19 in Children. Indian Pediatr. 2022;59(5):393-9.
137. Wilcha RJ. Does Wearing a Face Mask During the COVID-19 Pandemic Increase the Incidence of Dermatological Conditions in Health Care Workers? Narrative Literature Review. JMIR Dermatol. 2021;4(1):e22789.
138. Criado PR, Miot HA, Pincelli TPH, Fabro AT. From dermatological conditions to COVID-19: Reasoning for anticoagulation, suppression of inflammation, and hyperbaric oxygen therapy. Dermatol Ther. 2021;34(1):e14565.
139. Khurana A, Saxena S. Immunosuppressive agents for dermatological indications in the ongoing COVID-19 pandemic: Rationalizing use and clinical applicability. Dermatol Ther. 2020;33(4):e13639.
140. Raju SP, Sachdev M, Khunger N, Madnani N. Mask Acne in Skin of Color: A Significant Dermatological Condition Amidst the COVID-19 Pandemic. J Clin Aesthet Dermatol. 2022;15(4):44-8.
141. National Institute for Health and Care Excellence: Guidelines. COVID-19 rapid guideline: dermatological conditions treated with drugs affecting the immune response. London: National Institute for Health and Care Excellence (NICE)
Copyright © NICE 2021.; 2021.
142. Conde Hurtado DI, Vergara Rueda JI, Bermudez Florez JL, Cadena Infante SC, Rodriguez Morales AJ. Potential Dermatological Conditions Resulting from a Prolonged Stay at Home during the COVID-19 Pandemic: A Review. Acta Dermatovenerol Croat. 2021;29(3):135-47.
143. Munisamy M, Singh B, Pandhi D. Recommendations for COVID Vaccination for Dermatological Patients on Immunosuppressive/Immunomodulatory Therapy (IADVL Academy). Indian Dermatol Online J. 2021;12(Suppl 1):S4-s11.
144. Marraha F, Al Faker I, Gallouj S. A Review of the Dermatological Manifestations of Coronavirus Disease 2019 (COVID-19). Dermatol Res Pract. 2020;2020:9360476.
145. Simonetti O, Rizzetto G, Molinelli E, Diotallevi F, Radi G, Cirioni O, et al. Safety and Efficacy of Vaccines during COVID-19 Pandemic in Patients Treated with Biological Drugs in a Dermatological Setting. Healthcare (Basel). 2021;9(4).
146. Schwartz RA, Sharma A, Szepietowski JC, Sandhu S, Goldust M. Systemic Medications of Dermatological Importance in COVID-19. J Drugs Dermatol. 2020;19(9):889-92.
147. Bhogal P, Makalanda L, Hassan AE, Fiorella D, Andersson T, Ahmad M, et al. COVID-19 and Delayed Cerebral Ischemia-More in Common Than First Meets the Eye. J Clin Med. 2021;10(12).
148. Koh S, Rhee MK. COVID-19 and Dry Eye. Eye Contact Lens. 2021;47(6):317-22.
149. Sen M, Honavar SG, Sharma N, Sachdev MS. COVID-19 and Eye: A Review of Ophthalmic Manifestations of COVID-19. Indian J Ophthalmol. 2021;69(3):488-509.
150. Zubieta-Calleja G, Zubieta-DeUrioste N, Venkatesh T, Das KK, Soliz J. COVID-19 and Pneumolysis Simulating Extreme High-altitude Exposure with Altered Oxygen Transport Physiology; Multiple Diseases, and Scarce Need of Ventilators: Andean Condor's-eye-view. Rev Recent Clin Trials. 2020;15(4):347-59.
151. Feng Y, Armenti ST, Mian SI. COVID-19 and the Eye: A Comprehensive Review of the Literature. Int Ophthalmol Clin. 2021;61(1):1-14.
152. Domínguez-Varela IA, Rodríguez-Gutiérrez LA, Morales-Mancillas NR, Barrera-Sánchez M, Macías-Rodríguez Y, Valdez-García JE. COVID-19 and the eye: a review. Infect Dis (Lond). 2021;53(6):399-403.
153. Emparan JPO, Sardi-Correa C, López-Ulloa JA, Viteri-Soria J, Penniecook JA, Jimenez-Román J, et al. COVID-19 and the eye: how much do we really know? A best evidence review. Arq Bras Oftalmol. 2020;83(3):250-61.
154. Yener A. COVID-19 and the Eye: Ocular Manifestations, Treatment and Protection Measures. Ocul Immunol Inflamm. 2021;29(6):1225-33.
155. Al-Namaeh M. COVID-19 in the light of current clinical eye research. Eur J Ophthalmol. 2021;31(3):904-8.
156. Mansueto G. COVID-19: Brief check through the pathologist's eye (autopsy archive). Pathol Res Pract. 2020;216(11):153195.
157. de la Rica R, Borges M, Gonzalez-Freire M. COVID-19: In the Eye of the Cytokine Storm. Front Immunol. 2020;11:558898.
158. Sadhu S, Agrawal R, Pyare R, Pavesio C, Zierhut M, Khatri A, et al. COVID-19: Limiting the Risks for Eye Care Professionals. Ocul Immunol Inflamm. 2020;28(5):714-20.
159. Leonardi A, Salami E, Feuerman OM, Cavarzeran F. The effects of the COVID-19 pandemic on the treatment of allergic eye diseases. Curr Opin Allergy Clin Immunol. 2021;21(5):500-6.
160. Sopp NM, Sharda V. An Eye on COVID-19: A Meta-analysis of Positive Conjunctival Reverse Transcriptase-Polymerase Chain Reaction and SARS-CoV-2 Conjunctivitis Prevalence. Optom Vis Sci. 2021;98(5):429-36.
161. Durán CS, Mayorga GD. The eye: "An organ that must not be forgotten in coronavirus disease 2019 (COVID-2019) pandemic". J Optom. 2021;14(2):114-9.
162. Macarov M, Schneider N, Eilat A, Yahalom C. Genetic counseling practice for inherited eye diseases in an Israeli medical center during the COVID-19 pandemic. J Genet Couns. 2021;30(4):969-73.
163. El Hayek S, Cheaito MA, Nofal M, Abdelrahman D, Adra A, Al Shamli S, et al. Geriatric Mental Health and COVID-19: An Eye-Opener to the Situation of the Arab Countries in the Middle East and North Africa Region. Am J Geriatr Psychiatry. 2020;28(10):1058-69.
164. Wang H, Elsheikh M, Gilmour K, Cohen V, Sagoo MS, Damato B, et al. Impact of COVID-19 pandemic on eye cancer care in United Kingdom. Br J Cancer. 2021;124(8):1357-60.
165. Agoro R. In the COVID-19 era, let's keep an eye on clinical trials in Africa. J Glob Health. 2020;10(2):020312.
166. Park JF, Banerjee S, Umar S. In the eye of the storm: the right ventricle in COVID-19. Pulm Circ. 2020;10(3):2045894020936660.
167. De Virgiliis F, Di Giovanni S. Lung innervation in the eye of a cytokine storm: neuroimmune interactions and COVID-19. Nat Rev Neurol. 2020;16(11):645-52.
168. Barabino S. A Narrative Review of Current Understanding and Classification of Dry Eye Disease with New Insights on the Impact of Dry Eye during the COVID-19 Pandemic. Ophthalmol Ther. 2021;10(3):495-507.
169. Yeoh SH, Yong GY, Husni MA. New norms in ophthalmic surgery during the COVID-19 pandemic: A narrative review from a Malaysia tertiary eye care center. Eur J Ophthalmol. 2022;32(1):Np316-np7.
170. Bertoli F, Veritti D, Danese C, Samassa F, Sarao V, Rassu N, et al. Ocular Findings in COVID-19 Patients: A Review of Direct Manifestations and Indirect Effects on the Eye. J Ophthalmol. 2020;2020:4827304.
171. Carneiro VLA, Andrade H, Matias L, de Sousa R. Post-COVID-19 and the Portuguese national eye care system challenge. J Optom. 2020;13(4):257-61.
172. Hinduja RH, George K, Barthwal M, Pareek V. Radiation oncology in times of COVID-2019: A review article for those in the eye of the storm - An Indian perspective. Semin Oncol. 2020;47(5):315-27.
173. Gegúndez-Fernández JA, Zarranz-Ventura J, Garay-Aramburu G, Muñoz-Negrete FJ, Mendicute Del Barrio J, Pablo-Júlvez L, et al. Recommendations for eye care during the alarm state by the coronavirus disease pandemic COVID-19. Arch Soc Esp Oftalmol (Engl Ed). 2020;95(6):300-10.
174. Gulias-Cañizo R, Ruíz-Leyja ED, Sánchez-Huerta V, Ochoa-de la Paz L. SARS-CoV-2 and the Eye: A Relationship for a Possible Prognostic Tool in COVID-19 Patients. Clin Ophthalmol. 2021;15:707-12.
175. Emadi-Baygi M, Ehsanifard M, Afrashtehpour N, Norouzi M, Joz-Abbasalian Z. Corona Virus Disease 2019 (COVID-19) as a System-Level Infectious Disease With Distinct Sex Disparities. Front Immunol. 2021;12:778913.
176. Li Z, Jiang J, Tong Y, Ruan X, Xu J. COVID-19 is a natural infectious disease. J Biosaf Biosecur. 2022;4(1):38-42.
177. Lim RK, Kalagara S, Chen KK, Mylonakis E, Kroumpouzos G. Dermatology in a multidisciplinary approach with infectious disease and obstetric medicine against COVID-19. Int J Womens Dermatol. 2021;7(5):640-6.
178. Kunduru KR, Kutner N, Nassar-Marjiya E, Shaheen-Mualim M, Rizik L, Farah S. Disinfectants role in the prevention of spreading the COVID-19 and other infectious diseases: The need for functional polymers! Polym Adv Technol. 2022.
179. Brain D, Plant-Hately A, Heaton B, Arshad U, David C, Hedrich C, et al. Drug delivery systems as immunomodulators for therapy of infectious disease: Relevance to COVID-19. Adv Drug Deliv Rev. 2021;178:113848.
180. Patel N, Bouchard J, Oliver MB, Badowski ME, Carreno JJ. Early clinical trial data and real-world assessment of COVID-19 vaccines: Insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2021;41(10):837-50.
181. C SP, M MP. The evolution of rapid antigen detection systems and their application for COVID-19 and other serious respiratory infectious diseases. J Microbiol Immunol Infect. 2021;54(5):776-86.
182. Kondo KK, Williams BE, Ayers CK, Kansagara D, Smith M, Advani SM, et al. Factors Associated with Health Inequalities in Infectious Disease Pandemics Predating COVID-19 in the United States: A Systematic Review. Health Equity. 2022;6(1):254-69.
183. Whear R, Abbott RA, Bethel A, Richards DA, Garside R, Cockcroft E, et al. Impact of COVID-19 and other infectious conditions requiring isolation on the provision of and adaptations to fundamental nursing care in hospital in terms of overall patient experience, care quality, functional ability, and treatment outcomes: systematic review. J Adv Nurs. 2022;78(1):78-108.
184. Finsterer J, Scorza FA. Infectious and immune-mediated central nervous system disease in 48 COVID-19 patients. J Clin Neurosci. 2021;90:140-3.
185. Tsakiri M, Naziris N, Demetzos C. Innovative vaccine platforms against infectious diseases: Under the scope of the COVID-19 pandemic. Int J Pharm. 2021;610:121212.
186. Zhang C, Hong L, Ma N, Sun G. Logic Analysis of How the Emergency Management Legal System Used to Deal with Public Emerging Infectious Diseases under Balancing of Competing Interests-The Case of COVID-19. Healthcare (Basel). 2021;9(7).
187. Buonsenso D, Di Gennaro L, De Rose C, Morello R, D'Ilario F, Zampino G, et al. Long-term outcomes of pediatric infections: from traditional infectious diseases to long Covid. Future Microbiol. 2022;17:551-71.
188. Jit M, Ananthakrishnan A, McKee M, Wouters OJ, Beutels P, Teerawattananon Y. Multi-country collaboration in responding to global infectious disease threats: lessons for Europe from the COVID-19 pandemic. Lancet Reg Health Eur. 2021;9:100221.
189. Wu Q, Li Q, Lu J. A One Health strategy for emerging infectious diseases based on the COVID-19 outbreak. J Biosaf Biosecur. 2022;4(1):5-11.
190. Fazeli P, Saeidnia M, Erfani M, Kalani M. An overview of the biological and multifunctional roles of IL-38 in different infectious diseases and COVID-19. Immunol Res. 2022:1-9.
191. Bivins A, Kaya D, Ahmed W, Brown J, Butler C, Greaves J, et al. Passive sampling to scale wastewater surveillance of infectious disease: Lessons learned from COVID-19. Sci Total Environ. 2022;835:155347.
192. Kim SB, Ryoo S, Huh K, Joo EJ, Kim YJ, Choi WS, et al. Revised Korean Society of Infectious Diseases/National Evidence-based Healthcarea Collaborating Agency Guidelines on the Treatment of Patients with COVID-19. Infect Chemother. 2021;53(1):166-219.
193. Sims S, Harris R, Hussein S, Rafferty AM, Desai A, Palmer S, et al. Social Distancing and Isolation Strategies to Prevent and Control the Transmission of COVID-19 and Other Infectious Diseases in Care Homes for Older People: An International Review. Int J Environ Res Public Health. 2022;19(6).
194. Bayeh R, Yampolsky MA, Ryder AG. The Social Lives of Infectious Diseases: Why Culture Matters to COVID-19. Front Psychol. 2021;12:648086.
195. Vardoulakis S, Espinoza Oyarce DA, Donner E. Transmission of COVID-19 and other infectious diseases in public washrooms: A systematic review. Sci Total Environ. 2022;803:149932.
196. Mormeneo Bayo S, García-Lechuz Moya JM. What happened to infectious diseases and anti-infective therapy in 2020 beyond COVID-19? Rev Esp Quimioter. 2021;34 Suppl 1(Suppl1):8-11.
197. Rusu LC, Ardelean LC, Tigmeanu CV, Matichescu A, Sauciur I, Bratu EA. COVID-19 and Its Repercussions on Oral Health: A Review. Medicina (Kaunas). 2021;57(11).
198. Boyapati R, Dhulipalla R, Kolaparthy LK, Bodduru R. COVID-19 and oral implications: An updated review. J Oral Maxillofac Pathol. 2021;25(3):400-3.
199. Kusiak A, Cichońska D, Tubaja M, Skorek A, Jereczek-Fossa BA, Corrao G, et al. COVID-19 manifestation in the oral cavity - a narrative literature review. Acta Otorhinolaryngol Ital. 2021;41(5):395-400.
200. Janjua OS, Shaikh MS, Fareed MA, Qureshi SM, Khan MI, Hashem D, et al. Dental and Oral Manifestations of COVID-19 Related Mucormycosis: Diagnoses, Management Strategies and Outcomes. J Fungi (Basel). 2021;8(1).
201. Imran M, Kumar Arora M, Asdaq SMB, Khan SA, Alaqel SI, Alshammari MK, et al. Discovery, Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19. Molecules. 2021;26(19).
202. Ettinger R, Marchini L, Zwetchkenbaum S. The Impact of COVID-19 on the Oral Health of Patients with Special Needs. Dent Clin North Am. 2022;66(2):181-94.
203. Stennett M, Tsakos G. The impact of the COVID-19 pandemic on oral health inequalities and access to oral healthcare in England. Br Dent J. 2022;232(2):109-14.
204. Cerqueira T, Batista SG, de Mello EB, DosSantos MF, Tuñas ITC. Impact of the COVID-19 Pandemic on Stress, Sleep, and Oral Health in University Students. Front Pain Res (Lausanne). 2021;2:744264.
205. France K, Glick M. Long COVID and oral health care considerations. J Am Dent Assoc. 2022;153(2):167-74.
206. Al-Taie A, Denkdemir FR, Sharief Z, Buyuk AS, Şardaş S. The Long View on COVID-19 Theranostics and Oral Antivirals: Living with Endemic Disease and Lessons from Molnupiravir. Omics. 2022.
207. Silveira FM, Mello ALR, da Silva Fonseca L, Dos Santos Ferreira L, Kirschnick LB, Martins MD, et al. Morphological and tissue-based molecular characterization of oral lesions in patients with COVID-19: A living systematic review. Arch Oral Biol. 2022;136:105374.
208. Zhou X, Dong J, Guo Q, Li M, Li Y, Cheng L, et al. The Oral Complications of COVID-19. Front Mol Biosci. 2021;8:803785.
209. Nascimento RB, Araujo NS, Silva JC, Xavier FCA. Oral manifestations of multisystemic inflammatory syndrome in children (MIS-C) and Kawasaki disease associated to COVID-19: A systematic review. Spec Care Dentist. 2022;42(3):266-80.
210. Bhujel N, Zaheer K, Singh RP. Oral mucosal lesions in patients with COVID-19: a systematic review. Br J Oral Maxillofac Surg. 2021;59(9):1024-30.
211. Drozdzik A, Drozdzik M. Oral Pathology in COVID-19 and SARS-CoV-2 Infection-Molecular Aspects. International journal of molecular sciences. 2022;23(3).
212. Sharma P, Malik S, Wadhwan V, Gotur Palakshappa S, Singh R. Prevalence of oral manifestations in COVID-19: A systematic review. Rev Med Virol. 2022:e2345.
213. Hüpsch-Marzec H, Dziedzic A, Skaba D, Tanasiewicz M. The spectrum of non-characteristic oral manifestations in COVID-19 - a scoping brief commentary. Med Pr. 2021;72(6):685-92.
214. Herman P, Vincent C, Parietti Winkler C, Loundon N, Couloigner V, Tankere F, et al. Consensus statement. Corticosteroid therapy in ENT in the context of the COVID-19 pandemic. Eur Ann Otorhinolaryngol Head Neck Dis. 2020;137(4):315-7.
215. Sharma A, Bhardwaj R. COVID-19 and ENT surgery: a brief review of essential precautions and triage. Eur Arch Otorhinolaryngol. 2021;278(5):1301-5.
216. El-Anwar MW, Elzayat S, Fouad YA. ENT manifestation in COVID-19 patients. Auris Nasus Larynx. 2020;47(4):559-64.
217. Din T, Abdalla T, Chiesa-Estomba C, Simon F, Teissier N, Thomas I, et al. YO-IFOS Guidelines for Pediatric ENT Surgery during COVID-19: An Overview of Recommendations. Laryngoscope. 2021;131(8):1876-83.
Downloads
Published
Issue
Section
Categories
License
Copyright (c) 2022 PreferPub and Kindle
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Since making research freely available supports a greater global exchange of knowledge, PreferPub provides immediate open access to its published books under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (CC BY-NC 4.0). This license allows others to share, copy, and redistribute the material in any medium or format, as well as adapt, remix, transform, and build upon the material, as long as the use is non-commercial and appropriate credit is given to the original work.
